What are the new emergency room guidelines for migraine treatment proposed by Dr. Serena Orr?

The updated guidelines recommend offering occipital nerve blocks to treat acute migraine attacks in emergency rooms.

Why are opioids not recommended for migraine treatment according to the new research?

Opioids are not recommended due to the availability of better treatments and the significant risk of addiction.

How effective is the occipital nerve block for migraine relief?

Patients report significant pain relief within 30 minutes, with effects lasting around 24 hours.

Home / Health / Doctor's Own Migraine Sparks Medical Breakthrough

Doctor's Own Migraine Sparks Medical Breakthrough

6 Dec

•

Summary

Neurologist's personal migraine attack provided new perspective.
Updated guidelines recommend occipital nerve blocks for ER migraine treatment.
Study advises against opioids, favoring safer migraine management alternatives.

A personal experience with a severe migraine attack inspired neurologist Dr. Serena Orr to gain a new perspective on patient care. This led to her collaboration on updated guidelines for managing migraine attacks in emergency departments. The revised recommendations, published in Headache: The Journal of Head and Face Pain, advocate for offering occipital nerve blocks as a primary treatment.

These updated guidelines, reviewing 26 recent studies, represent a significant shift in emergency migraine care. The use of occipital nerve blocks, involving anesthetic injections near nerves at the base of the skull, is highlighted for its efficacy in altering pain signaling and providing rapid relief. This approach aims to improve patient outcomes and decrease dependency on potentially addictive medications.

The research strongly advises against the use of opioids for migraine treatment due to better available alternatives and concerns about addiction. While opioid prescriptions for migraines have decreased, they remain common. The new guidance is being shared with medical societies in Canada and beyond to encourage wider implementation, offering hope to millions suffering from this debilitating neurological disease.